Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
170.28
Dollar change
+0.37
Percentage change
0.22
%
IndexS&P 500 P/E50.70 EPS (ttm)3.36 Insider Own0.10% Shs Outstand1.77B Perf Week1.81%
Market Cap300.69B Forward P/E14.14 EPS next Y12.05 Insider Trans-20.63% Shs Float1.76B Perf Month1.54%
Income5.95B PEG8.16 EPS next Q2.85 Inst Own72.36% Short Float0.92% Perf Quarter1.65%
Sales54.40B P/S5.53 EPS this Y-0.37% Inst Trans0.10% Short Ratio2.93 Perf Half Y3.27%
Book/sh4.53 P/B37.55 EPS next Y8.83% ROA4.20% Short Interest16.22M Perf Year26.15%
Cash/sh10.23 P/C16.64 EPS next 5Y6.21% ROE55.92% 52W Range132.70 - 182.89 Perf YTD9.88%
Dividend Est.6.18 (3.63%) P/FCF13.76 EPS past 5Y-5.77% ROI8.29% 52W High-6.89% Beta0.62
Dividend TTM6.06 (3.56%) Quick Ratio0.83 Sales past 5Y11.76% Gross Margin68.99% 52W Low28.32% ATR (14)3.10
Dividend Ex-DateJul 15, 2024 Current Ratio0.94 EPS Y/Y TTM-21.01% Oper. Margin31.87% RSI (14)55.74 Volatility1.54% 1.79%
Employees50000 Debt/Eq9.24 Sales Y/Y TTM-4.12% Profit Margin10.94% Recom1.79 Target Price184.05
Option/ShortYes / Yes LT Debt/Eq7.97 EPS Q/Q496.96% Payout220.33% Rel Volume0.74 Prev Close169.91
Sales Surprise3.19% EPS Surprise2.24% Sales Q/Q0.70% EarningsJul 25 BMO Avg Volume5.54M Price170.28
SMA200.76% SMA503.23% SMA2005.64% Trades Volume4,113,547 Change0.22%
Date Action Analyst Rating Change Price Target Change
Jun-05-24Upgrade HSBC Securities Hold → Buy $185
May-17-24Initiated Cantor Fitzgerald Overweight $200
Jan-29-24Upgrade William Blair Mkt Perform → Outperform
Dec-18-23Downgrade HSBC Securities Buy → Hold
Dec-11-23Upgrade Goldman Neutral → Buy
Nov-09-23Initiated Deutsche Bank Hold $150
Oct-30-23Upgrade Barclays Equal Weight → Overweight $160 → $170
Oct-20-23Resumed UBS Neutral $157 → $150
Sep-29-23Initiated Raymond James Outperform $177
Jul-25-23Initiated William Blair Mkt Perform
Jul-12-24 08:30AM
Jul-11-24 05:45PM
10:14AM
09:00AM
Jul-10-24 08:00AM
07:48AM Loading…
07:48AM
Jul-09-24 08:00AM
07:40AM
Jul-08-24 05:50AM
Jul-03-24 03:07PM
Jul-02-24 04:45PM
01:10PM
08:00AM
06:24AM
Jul-01-24 04:30PM
01:40PM Loading…
01:40PM
10:48AM
08:37AM
08:00AM
06:50AM
01:00AM
Jun-30-24 10:13AM
Jun-29-24 03:23PM
Jun-28-24 04:37PM
11:02AM
08:51AM
06:13AM
04:12AM
02:00AM
Jun-27-24 11:03AM
10:37AM Loading…
10:37AM
09:26AM
09:00AM
08:30AM
06:22AM
05:30AM
04:32AM
Jun-26-24 07:03PM
09:05AM
07:00AM
05:12AM
Jun-25-24 05:45PM
01:27PM
09:58AM
08:15AM
08:13AM
08:00AM
04:31AM
Jun-24-24 11:25AM
Jun-22-24 09:03AM
Jun-21-24 02:00PM
08:00AM
Jun-20-24 09:00AM
08:41AM
08:00AM
07:30AM
06:00AM
Jun-19-24 01:53PM
01:09PM
11:45AM
09:50AM
08:45AM
04:19AM
04:12AM
Jun-18-24 06:18PM
05:45PM
01:34PM
06:13AM
Jun-16-24 08:30AM
Jun-14-24 04:08PM
01:45PM
08:50AM
08:09AM
07:15AM
04:12AM
Jun-13-24 12:00PM
09:05AM
07:59AM
Jun-12-24 09:00AM
Jun-11-24 08:00AM
08:00AM
Jun-10-24 05:45PM
Jun-07-24 10:18AM
07:30AM
06:46AM
Jun-06-24 03:07PM
02:58PM
02:44PM
02:25PM
11:53AM
08:45AM
08:30AM
08:00AM
06:19AM
06:00AM
04:45AM
Jun-05-24 05:37PM
10:00AM
09:30AM
09:00AM
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Donoghoe NicholasEVP, CHIEF BUS/STRAT OFFICERMar 20 '24Sale176.3021,0823,716,75755,903Mar 22 05:00 PM
Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICERMar 18 '24Option Exercise61.3626,1101,602,110119,890Mar 20 05:00 PM
Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICERMar 18 '24Sale178.7958,94910,539,50860,941Mar 20 05:00 PM
RICHMOND TIMOTHY J.EVP, CHIEF HR OFFICERMar 01 '24Option Exercise61.3645,7002,804,15289,517Mar 05 05:30 PM
RICHMOND TIMOTHY J.EVP, CHIEF HR OFFICERMar 01 '24Sale177.2775,68013,415,50313,837Mar 05 05:30 PM
Michael Robert A.PRES & CHIEF OPERATING OFFICERFeb 29 '24Option Exercise58.3021,5601,257,012167,524Mar 01 05:50 PM
Michael Robert A.PRES & CHIEF OPERATING OFFICERFeb 29 '24Sale176.4568,87912,153,95798,645Mar 01 05:50 PM
Siatis Perry CEVP, GC AND SECRETARYFeb 29 '24Sale177.399,8911,754,55510,397Mar 01 05:50 PM
Buckbee Kevin KSVP, CONTROLLERFeb 29 '24Sale176.655,144908,6886,983Mar 01 05:50 PM
GONZALEZ RICHARD ACHAIRMAN OF THE BOARD AND CEOFeb 28 '24Sale177.27138,61624,572,458519,099Mar 01 05:50 PM
Siatis Perry CEVP, GC AND SECRETARYFeb 23 '24Option Exercise137.3613,7531,889,11541,926Feb 27 05:10 PM
Reents Scott TEVP, CHIEF FINANCIAL OFFICERFeb 23 '24Option Exercise61.3614,140867,63041,205Mar 01 05:50 PM
Reents Scott TEVP, CHIEF FINANCIAL OFFICERFeb 23 '24Sale177.4414,1402,509,00227,065Mar 01 05:50 PM
Siatis Perry CEVP, GC AND SECRETARYFeb 23 '24Sale177.5113,7532,441,29528,173Feb 27 05:10 PM
SALEKI-GERHARDT AZITAEVP, CHIEF OPERATIONS OFFICERFeb 21 '24Option Exercise58.8852,8703,112,986296,814Feb 23 05:00 PM
SALEKI-GERHARDT AZITAEVP, CHIEF OPERATIONS OFFICERFeb 21 '24Sale173.7152,8709,184,048243,944Feb 23 05:00 PM
Donoghoe NicholasEVP, CHIEF BUS/STRAT OFFICERDec 26 '23Sale154.722,912450,54555,903Dec 28 05:00 PM
GONZALEZ RICHARD ACHAIRMAN OF THE BOARD AND CEOAug 01 '23Sale148.5860,0008,914,800565,294Aug 02 05:07 PM
GONZALEZ RICHARD ACHAIRMAN OF THE BOARD AND CEOJul 31 '23Sale149.1518,5002,759,275625,294Aug 02 05:07 PM